石药集团将携5.26亿元重整ST景峰

河北资本
Oct 28, 2025

点击蓝字关注我们一、ST景峰重整背景ST景峰主营化学药、生物药及中成药的研发、制造与销售,曾因股价异动被称为A股“涨停王”,但行业政策调整成为其业绩断崖式下滑的转折点。2019年医保控费、辅助用药重点监控等政策落地后,核心产品参芎葡萄糖注射液未进入国家医保目录,榄香烯乳状注射液医保支付范围大幅缩窄,两大主力产品收入暴跌70.31% 。2019-2023年,公司归母净利润累计亏损达23.71亿元,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10